ANGELA OAKLEY: Open Payments
NPI 1104288620 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,418 in 80 payments from 15 companies in 2025. Trend: 2023 $119 · 2024 $77 · 2025 $1,418
Food & beverage: $1,418
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $478 |
| Otsuka America Pharmaceutical, Inc. | 7 | $175 |
| Lundbeck LLC | 7 | $168 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $122 |
| Almatica Pharma LLC | 5 | $91 |
| Alkermes, Inc. | 3 | $83 |
| Biogen, Inc. | 3 | $69 |
| Collegium Pharmaceutical, Inc. | 3 | $56 |
| Teva Pharmaceuticals USA, Inc. | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
Products named: VRAYLAR, REXULTI, CAPLYTA, LOREEV XR, LYBALVI, ABILIFY ASIMTUFII, ZURZUVAE, Jornay PM.
Industry payments across AZ — which companies pay providers there.
